PRKCD and colonic neoplasm: PEP005 was shown to modulate PKCs by activating PKCδ in human myeloid leukemia cancer cell lines, thereby inducing cellular apoptosis in melanoma [234] and in colon cancer models [235] through the inhibition of the AKT signaling pathway [236].